For example, in Alzheimer’s disease, which is characterised by synapse loss during the early stages, it would be informative to determine whether and how SV2A-positive synapse types and subtypes are affected at the different stages of disease progression. The gene discussed is SV2A; the disease is Alzheimer disease.